Ignite Creation Date:
2024-05-06 @ 1:11 AM
Last Modification Date:
2024-10-26 @ 11:01 AM
Study NCT ID:
NCT01758666
Status:
UNKNOWN
Last Update Posted:
2015-12-22
First Post:
2012-08-30
Brief Title:
A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2012-12
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
At present the most effective drugs to osteosarcoma include ADMDDPHD-MTXIFO and so onThe effective rate of single drug was about 30 and if the chemotherapy contains HD-MTX the survival rate can reach about 60 so the HD-MTX is the most important component in patients of osteosarcoma
Studies have shown that MTX efficacy and adverse reactions were associated with blood concentration level and duration selecting the right time and dose to give CF is the critical point
Studies have shown that MTX efficacy and adverse reactions were associated with blood concentration level and duration selecting the right time and dose to give CF is the critical point
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None